David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$327M |
| 2 |
Netflix
NFLX
|
+$275M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$219M |
| 4 |
Citigroup
C
|
+$211M |
| 5 |
Merck
MRK
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DELL
DELL INC
DELL
|
+$558M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$259M |
| 3 |
Meta Platforms (Facebook)
META
|
+$252M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$252M |
| 5 |
IBM
IBM
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.49% |
| 2 | Technology | 7.17% |
| 3 | Consumer Discretionary | 7.02% |
| 4 | Healthcare | 6.66% |
| 5 | Communication Services | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
JetBlue
JBLU
$1.88B
| $966K | ﹤0.01% |
112,988
-88,706
| -44% | -$704K |
|
3177
Healthpeak Properties
DOC
$14.9B
| $965K | ﹤0.01% |
29,173
-507,935
| -95% | -$18.1M |
|
3178
PUT
LPL Financial
LPLA
$28.4B
| $964K | ﹤0.01% |
20,500
| – | – |
|
3179
CALL
Quaker Houghton
KWR
$2.83B
| $963K | ﹤0.01% |
12,500
-5,500
| -31% | -$423K |
|
|
BMS
3180
CALL
DELISTED
Bemis
BMS
| $963K | ﹤0.01% |
23,500
-10,700
| -31% | -$421K |
|
|
CKP
3181
DELISTED
CHECKPOINT SYSTEMS INC
CKP
| $960K | ﹤0.01% |
60,881
+42,353
| +229% | +$664K |
|
|
BITA
3182
CALL
DELISTED
Bitauto Holdings Limited
BITA
| $959K | ﹤0.01% |
+30,000
| New | +$803K |
|
|
NILE
3183
DELISTED
Blue Nile, Inc.
NILE
| $959K | ﹤0.01% |
20,363
-44,249
| -68% | -$1.92M |
|
|
CIVI
3184
DELISTED
Civitas Resources
CIVI
| $957K | ﹤0.01% |
+197
| New | +$1.06M |
|
3185
Patrick Industries
PATK
$2.69B
| $957K | ﹤0.01% |
111,611
+38,265
| +52% | +$338K |
|
|
AVTA
3186
CALL
DELISTED
Avantax, Inc. Common Stock
AVTA
| $956K | ﹤0.01% |
32,800
+12,700
| +63% | +$343K |
|
|
CUB
3187
DELISTED
Cubic Corporation
CUB
| $955K | ﹤0.01% |
18,138
+777
| +4% | +$41K |
|
|
CLMS
3188
DELISTED
Calamos Asset Management, Inc.
CLMS
| $955K | ﹤0.01% |
80,670
+2,049
| +3% | +$21.3K |
|
3189
CALL
Teva Pharmaceuticals
TEVA
$44.2B
| $954K | ﹤0.01% |
23,800
| – | – |
|
|
SPLS
3190
CALL
DELISTED
Staples Inc
SPLS
| $953K | ﹤0.01% |
60,000
| – | – |
|
3191
Consolidated Edison
ED
$40B
| $952K | ﹤0.01% |
17,210
-33,528
| -66% | -$1.89M |
|
|
GLF
3192
CALL
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
| $952K | ﹤0.01% |
20,200
-6,000
| -23% | -$297K |
|
|
CASC
3193
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $951K | ﹤0.01% |
90,053
+6,838
| +8% | +$76.4K |
|
3194
Banco de Chile
BCH
$21B
| $948K | ﹤0.01% |
36,341
+9,889
| +37% | +$262K |
|
3195
PUT
Exelon
EXC
$45.8B
| $948K | ﹤0.01% |
48,509
-203,851
| -81% | -$4.1M |
|
|
CERN
3196
CALL
DELISTED
Cerner Corp
CERN
| $948K | ﹤0.01% |
17,000
| – | – |
|
|
STI
3197
CALL
DELISTED
SunTrust Banks, Inc.
STI
| $946K | ﹤0.01% |
25,700
-39,300
| -60% | -$1.37M |
|
3198
CALL
New Oriental
EDU
$9.19B
| $945K | ﹤0.01% |
+30,000
| New | +$835K |
|
3199
National Grid
NGG
$81B
| $944K | ﹤0.01% |
14,986
-87,068
| -85% | -$5.22M |
|
|
AXE
3200
DELISTED
Anixter International Inc
AXE
| $944K | ﹤0.01% |
10,515
-62,360
| -86% | -$5.42M |
|
Similar funds
David Shaw's Q4 2013 Portfolio in Review
As of Q4 2013, David Shaw held 4,972 positions worth $73.3B, up 17% from $62.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
David Shaw deployed $3.59B of net new capital in Q4 2013, opening 721 new positions and adding to 1,786 existing holdings. Its largest new stake was Allegion: 2,233,249 shares worth $98.7M.
By sector, the portfolio is most concentrated in Financials at 7.5% of assets, up from 7% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $252M trimmed.
- David Shaw's largest Q4 2013 buy was Allegion: 2,233,249 shares worth $98.7M.
- David Shaw added most to Bank of America in Q4 2013, an estimated $327M increase.
- David Shaw's biggest Q4 2013 reduction was Meta Platforms (Facebook), cutting an estimated $252M.
- David Shaw fully exited DELL INC in Q4 2013, selling an estimated $558M.
- David Shaw's ten largest holdings make up 13% of its $73.3B portfolio in Q4 2013.
- David Shaw opened 721 new positions and closed 549 in Q4 2013.
- David Shaw's portfolio value rose 17% quarter-over-quarter to $73.3B.
Based on D.E. Shaw & Co's 13F filing for Q4 2013, filed 14 Feb 2014.